Identification of novel TMEM16A blockers through integrated virtual screening, molecular dynamics, and experimental studies
Abstract The calcium-activated chloride channel TMEM16A is a promising drug target for treating hypertension, secretory diarrheas, and various cancers, including head and neck cancer. Despite its potential, no FDA-approved drugs have provided the structural basis for directly inhibiting TMEM16A. Thi...
Saved in:
| Main Authors: | Mattanun Sangkhawasi, Wichuda Pitaktrakul, Rungtiwa Khumjiang, Yasuteru Shigeta, Chatchai Muanprasat, Kowit Hengphasatporn, Thanyada Rungrotmongkol |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-99751-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Afatinib amplifies cAMP-induced fluid secretion in a mouse mini-gut model via TMEM16A-mediated fluid secretion and secretory cell differentiation
by: Jutharat Ariyadamrongkwan, et al.
Published: (2025-08-01) -
Comprehensive analysis of TMEM9 in human tumors
by: Xuezhong Zhang, et al.
Published: (2025-03-01) -
Mitochondrial Encephalocardio-Myopathy with Neonatal Hypotonia and TMEM70 Mutation
by: J Gordon Millichap
Published: (2010-05-01) -
Simulation-based survey of TMEM16 family reveals that robust lipid scrambling requires an open groove
by: Christina Alexandra Stephens, et al.
Published: (2025-08-01) -
TMEM16A in prostate cancer: mechanistic insights and therapeutic implications
by: Jia Wei He, et al.
Published: (2025-07-01)